Costunolide protects lipopolysaccharide/d-galactosamine-induced acute liver injury in mice by inhibiting NF-κB signaling pathway

In conclusion, this study suggested that costunolide could attenuate LPS/D-Gal-induced liver injury and might be a potential therapeutic reagent for liver injury.